Excellent response to oral zolpidem in a sporadic case of the myoclonus dystonia syndrome

Movement Disorders

Volumn 24, Issue 14, 2009, Pages 2172-2173

  Park, In Seok ^a   Kim, Joong Seok ^a   An, Jae Young ^a   Kim, Yeong In ^a   Lee, Kwang Soo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; ZOLPIDEM TARTRATE;

ADULT; CASE REPORT; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG RESPONSE; DYSTONIA; FEMALE; FOREHEAD; HUMAN; INVOLUNTARY MOVEMENT; LETTER; MYOCLONUS; MYOCLONUS DYSTONIA; NECK; PRIORITY JOURNAL; SOMNOLENCE; STRESS; SYMPTOM;

ADULT; DYSTONIA; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MYOCLONUS; NECK MUSCLES; PYRIDINES;

EID: 70450161977     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22745     Document Type: Letter

References (7)

1. Abe K. Zolpidem therapy for movement disorders. Recent Pat CNS Drug Discov 2008;3:55-60.
2. Kinugawa K, Vidailhet M, Clot F, Apartis E, Grabli D, Roze E. Myoclonus-dystonia: an update. Mov Disord 2009;24:479-489.
3. Frucht SJ, Bordelon Y, Houghton WH, Reardan D. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord 2005;20:1330-1337. (Pubitemid 41645908)
4. Foncke EM, Bour LJ, Speelman JD, Koelman JH, Tijssen MA. Local field potentials and oscillatory activity of the internal globus pallidus in myoclonus-dystonia. Mov Disord 2007;22:369-376.
5. Marelli C, Canafoglia L, Zibordi F, et al. A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord 2008;23:2041-2048.
6. Nobrega JN, Richter A, Burnham WM, Lôscher W. Alterations in the brain GABAA/benzodiazepine receptor-chloride ionophore complex in a genetic model of paroxysmal dystonia: a quantitative autoradiographic analysis. Neuroscience 1995;64:229-239.
7. Snodgrass SR. Myoclonus: analysis of monoamine, GABA, and other systems. FASEB J 1990;4:2775-2788.